Aureka offers open-source AI module for drug discovery - pharmaphorum

The model covers structure prediction, antibody-antigen modelling, and drug research. According to the announcement, OpenDDE is designed to accelerate drug discovery by making advanced AI tools available to researchers without licensing fees.

The open-source release means that any organisation or individual can access and modify the model's code. Aureka stated that the model has been trained on a large dataset of molecular structures and interactions. The company claims that OpenDDE can perform tasks such as predicting protein folding, modelling antibody-antigen binding, and identifying potential drug candidates.

The move is part of a broader trend toward open-source AI in drug discovery, with several other companies and academic groups releasing similar models. Aureka noted that they will continue to update the model and provide support for researchers. The implications for drug development timelines and biosecurity remain subjects of debate among experts.